Abiomed
ABMD
#1118
Rank
โ‚น1.449 T
Marketcap
โ‚น32,149
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : โ‚น13.22 Billion

According to Abiomed's latest financial reports the company's total liabilities are โ‚น13.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31โ‚น12.89 B6.62%
2021-03-31โ‚น12.09 B6.24%
2020-03-31โ‚น11.38 B39.59%
2019-03-31โ‚น8.15 B29.33%
2018-03-31โ‚น6.30 B-1.02%
2017-03-31โ‚น6.37 B74.06%
2016-03-31โ‚น3.66 B25.11%
2015-03-31โ‚น2.92 B31.96%
2014-03-31โ‚น2.21 B24.08%
2013-03-31โ‚น1.78 B27.28%
2012-03-31โ‚น1.40 B17.24%
2011-03-31โ‚น1.19 B23.68%
2010-03-31โ‚น0.96 B-4.54%
2009-03-31โ‚น1.01 B4.07%
2008-03-31โ‚น0.97 B60.26%
2007-03-31โ‚น0.60 B50.95%
2006-03-31โ‚น0.40 B89.26%
2005-03-31โ‚น0.21 B1.83%
2004-03-31โ‚น0.20 B-29.62%
2003-03-31โ‚น0.29 B-40.32%
2002-03-31โ‚น0.49 B14.34%
2001-03-31โ‚น0.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น253.51 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.392 T 10,425.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.66 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA